Atypical fracture of the femur in a patient using denosumab-a case report

Acta Orthopaedica

Volumn 85, Issue 1, 2014, Pages 6-7

  Schilcher, Jörg ^a   Aspenberg, Per ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; DENOSUMAB; ZOLEDRONIC ACID;

BONE RADIOGRAPHY; CASE REPORT; FEMALE; FEMUR FRACTURE; FRACTURE HEALING; HUMAN; INTRAMEDULLARY NAILING; KIDNEY FUNCTION; KNEE PAIN; OSTEOPOROSIS; REVIEW; WALKER;

AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; BONE DENSITY CONSERVATION AGENTS; FEMALE; FEMORAL FRACTURES; FRACTURES, STRESS; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 84896809954     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.3109/17453674.2014.885355     Document Type: Review

References (5)

1. Aspenberg P. Denosumab and atypical femoral fractures. Acta Orthop 2014; 85 (1): 1-2.
2. Drampalos E, Skarpas G, Barbounakis N, Michos I. Atypical femoral fractures bilaterally in a patient receiving denosumab. Acta Orthop 2014; 85 (1): 3-5.
3. Paparodis R, Buehring B, Pelley EM, Binkley N. A case of an unusual subtrochanteric fracture in a patient receiving denosumab. Endocr Pract 2013; 19 (3): E64-8.
4. Schilcher J, Michaëlsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 201; 364 (18): 1728-37.
5. Thompson R N, Armstrong C, Heyburn G. Bilateral atypical femoral fractures in a patient prescribed denosumab - A case report. Bone 2013 Dec 31. pii: S8756-3282(13)00549-8. doi: 10.1016/j.bone.2013.12.027. [Epub ahead of print]